Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Elites 2 bead ADFs are creating a NEW Standard of Care
Once AD opiod is disturbed Naltrexone is released making it a placebo.
HAL studies support.
Elite's 2 bead ER and IR ADF opiods
Will be the first to obtain complete ORAL, Nasal and IV ADF labeling
SequestOx will make ALL other IR opiods obsolete.
Inspirion's RoxyBond lost big by not getting oral AD labeling

Reformulated SequestOx™ with lowered fed Tmax is the SAFEST Immediate Release opiod in the world, and the only one using a Pharmalogical Approach to abuse deterrence.
To date there have been no adverse events reported with Elites SequestOx™,
SequestOx had impeccable HAL studies.


SequestOx II™ Elite's market disruptive ADF labeled Immediate Release opiod
can not be abused by:

NASAL:
Insuffalation/snorting all particle sizes

IV:
injecting/IV/poor syringe ability

Smoking:

ORAL:
chewing
crushing/mechanical manipulation
grating
milling
sucking
splitting
breaking
grinding
use with alcohol
sandpapering
blended
melting
microwave
baking
freezing
extracting
centrifuging
bead separation
difficult to defeat with common solvents

ELTP